Company intelligence / Profile preview

Imavita

France

Ownership: Private
Development stage: Other

Overview

Imavita provides preclinical efficacy, safety, and pharmacokinetic data using advanced imaging and bioinformatics to pharmaceutical, biotechnology, and research laboratory clients, primarily in dermatology and other disease models. No clinical results as all work is preclinical.

Therapeutic areas: Dermatology
Modalities: Small moleculeBiologicUnlabeled compoundLabelled compound (imaging studies)
Industry: Contract Research Organization

Partnerships

Partnerships with pharmaceutical industries, biotechnology companies, and private/public laboratories (precise partners not disclosed)

Beyond the preview

Go deeper on Imavita.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Imavita.

Explore the full profile